humoral immune response against Survivin in patients with Lung cancer
Evaluation of the humoral immune response against survivin in patients with lung cancer
978-3-8465-5694-8
3846556947
92
2011-12-13
49.00 €
eng
https://images.our-assets.com/cover/230x230/9783846556948.jpg
https://images.our-assets.com/fullcover/230x230/9783846556948.jpg
https://images.our-assets.com/cover/2000x/9783846556948.jpg
https://images.our-assets.com/fullcover/2000x/9783846556948.jpg
This Book is presenting the Evaluation of the humoral immune response against survivin in patients with lung, Serum samples from 33 small cell lung cancer (SCLC) and 117 non-small cell lung cancer (NSCLC) patients upon diagnosis, and from 100 controls, were tested by ELISA for anti-survivin antibodies. We conclude that survivin does not induce considerable humoral responses in lung cancer. Potentially, however, strong anti-survivin antibody responses can be elicited during the follow-up of the patients, whose clinical significance remains to be elucidated. These findings, together with our previous data concerning survivin expression and the related cytolytic T cell responses in lung cancer, signify a high tolerogenic potential of this tumor-associated antigen.
https://www.morebooks.de/books/pt/published_by/lap-lambert-academic-publishing/47/products
Disciplinas não-clínicas
https://www.morebooks.de/store/pt/book/humoral-immune-response-against-survivin-in-patients-with-lung-cancer/isbn/978-3-8465-5694-8